Systemic IL-27 administration prevents abscess formation and osteolysis via local neutrophil recruitment and activation

[1]  E. Schwarz,et al.  Skeletal infections: microbial pathogenesis, immunity and clinical management , 2022, Nature Reviews Microbiology.

[2]  V. Alt,et al.  Intracellular S. aureus in Osteoblasts in a Clinical Sample from a Patient with Chronic Osteomyelitis—A Case Report , 2021, Pathogens.

[3]  E. Schwarz,et al.  Interleukin-27 and Its Diverse Effects on Bacterial Infections , 2021, Frontiers in Immunology.

[4]  R. G. Richards,et al.  Humanized Mice Exhibit Exacerbated Abscess Formation and Osteolysis During the Establishment of Implant-Associated Staphylococcus aureus Osteomyelitis , 2021, Frontiers in Immunology.

[5]  Yutian Wang,et al.  mRNA Transcriptome Analysis of Bone in a Mouse Model of Implant-Associated Staphylococcus aureus Osteomyelitis , 2021, Infection and Immunity.

[6]  E. Schwarz,et al.  Distinct vasculotropic versus osteotropic features of S. agalactiae versus S. aureus implant‐associated bone infection in mice , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  S. Kates,et al.  IsdB antibody–mediated sepsis following S. aureus surgical site infection , 2020, JCI insight.

[8]  S. Gill,et al.  Identification of Penicillin Binding Protein 4 (PBP4) as a critical factor for Staphylococcus aureus bone invasion during osteomyelitis in mice , 2020, PLoS pathogens.

[9]  R. Buckley,et al.  The AO trauma CPP bone infection registry: Epidemiology and outcomes of Staphylococcus aureus bone infection , 2020, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  Chun Jimmie Ye,et al.  IL-27: An endogenous constitutive repressor of human monocytes , 2020, Clinical immunology.

[11]  W. Obremskey,et al.  Pathogenesis and management of fracture-related infection. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  S. Kates,et al.  Commentary on Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition Originally Published in the Journal of Bone and Mineral Research. , 2020, Journal of orthopaedic trauma.

[13]  S. Mears,et al.  Streamlining Hospital Treatment of Prosthetic Joint Infection. , 2020, The Journal of arthroplasty.

[14]  Zhongjun Wu,et al.  IL-27 is elevated in sepsis with acute hepatic injury and promotes hepatic damage and inflammation in the CLP model. , 2019, Cytokine.

[15]  E. Schwarz,et al.  Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis , 2019, Current Osteoporosis Reports.

[16]  D. Backstein,et al.  Predictors of Treatment Failure for Hip and Knee Prosthetic Joint Infections in the Setting of 1- and 2-Stage Exchange Arthroplasty: A Multicenter Retrospective Cohort , 2019, Open forum infectious diseases.

[17]  F. Fang,et al.  Reactive nitrogen species in host-bacterial interactions. , 2019, Current opinion in immunology.

[18]  M. Verhofstad,et al.  Diagnosing Fracture-Related Infection: Current Concepts and Recommendations , 2019, Journal of orthopaedic trauma.

[19]  S. Gill,et al.  Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy” , 2019, Bone Research.

[20]  J. Fitzpatrick,et al.  Staphylococcus aureus Infects Osteoclasts and Replicates Intracellularly , 2019, mBio.

[21]  R. O’Toole,et al.  2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  N. Iwasaki,et al.  Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants. , 2019, Acta biomaterialia.

[23]  S. Dong,et al.  Interleukin-27 prevents LPS-induced inflammatory osteolysis by inhibiting osteoclast formation and function. , 2019, American journal of translational research.

[24]  H. Wong,et al.  Interleukin-27 as a candidate diagnostic biomarker for bacterial infection in immunocompromised pediatric patients , 2018, PloS one.

[25]  Jia Gu,et al.  fastp: an ultra-fast all-in-one FASTQ preprocessor , 2018, bioRxiv.

[26]  Liping Zhang,et al.  IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis , 2018, The Journal of infectious diseases.

[27]  A. Dessen,et al.  New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[28]  Yu He,et al.  Multiplex Cytokine Profiling Identifies Interleukin-27 as a Novel Biomarker For Neonatal Early Onset Sepsis , 2017, Shock.

[29]  S. Gupta,et al.  Interleukin 27 (IL-27) Alleviates Bone Loss in Estrogen-deficient Conditions by Induction of Early Growth Response-2 Gene* , 2017, The Journal of Biological Chemistry.

[30]  F. Gao,et al.  Interleukin-27 is elevated in sepsis-induced myocardial dysfunction and mediates inflammation. , 2016, Cytokine.

[31]  Jonathan P. Davis,et al.  Systemic delivery of IL‐27 by an adeno‐associated viral vector inhibits T cell‐mediated colitis and induces multiple inhibitory pathways in T cells , 2016, Journal of leukocyte biology.

[32]  H. Wong,et al.  Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill , 2015, Critical Care.

[33]  S. Kates,et al.  Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant‐associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors , 2015, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[34]  C. Hunter,et al.  The immunobiology of interleukin-27. , 2015, Annual review of immunology.

[35]  J. Alcorn,et al.  The role of IL-27 in susceptibility to post-influenza Staphylococcus aureus pneumonia , 2015, Respiratory Research.

[36]  F. Vandenesch,et al.  Antimicrobial Activity against Intraosteoblastic Staphylococcus aureus , 2015, Antimicrobial Agents and Chemotherapy.

[37]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[38]  R. Schnettler,et al.  Intracellular proliferation of S. aureus in osteoblasts and effects of rifampicin and gentamicin on S. aureus intracellular proliferation and survival. , 2014, European cells & materials.

[39]  H. Wong,et al.  Performance of interleukin-27 as a sepsis diagnostic biomarker in critically ill adults. , 2014, Journal of critical care.

[40]  S. Kates,et al.  Passive immunization with anti‐glucosaminidase monoclonal antibodies protects mice from implant‐associated osteomyelitis by mediating opsonophagocytosis of Staphylococcus aureus megaclusters , 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[41]  Peng Luo,et al.  IL-27 controls sepsis-induced impairment of lung antibacterial host defence , 2014, Thorax.

[42]  C. Lindsell,et al.  Interleukin 27 as a Sepsis Diagnostic Biomarker in Critically Ill Adults , 2013, Shock.

[43]  W. Shi,et al.  The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote , 2013, Nucleic acids research.

[44]  H. Wong,et al.  Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children , 2012, Critical Care.

[45]  D. Roos,et al.  The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology. , 2012, Immunity.

[46]  S. V. van Hal,et al.  Predictors of Mortality in Staphylococcus aureus Bacteremia , 2012, Clinical Microbiology Reviews.

[47]  K. Gee,et al.  Interleukin-27 induces a STAT1/3- and NF-κB-dependent proinflammatory cytokine profile in human monocytes. , 2012, The Journal of Biological Chemistry.

[48]  Xiao-Kui Guo,et al.  The effect of Staphylococcus aureus on apoptosis of cultured human osteoblasts , 2011, Orthopaedic surgery.

[49]  M. Volin,et al.  Local expression of interleukin-27 ameliorates collagen-induced arthritis. , 2011, Arthritis and rheumatism.

[50]  Timothy J. Foster,et al.  Staphylococcus aureus Protein A Binds to Osteoblasts and Triggers Signals That Weaken Bone in Osteomyelitis , 2011, PloS one.

[51]  C. Fielding,et al.  A role for IL-27p28 as an antagonist of gp130-mediated signaling , 2010, Nature Immunology.

[52]  David C Aron,et al.  Adherence to surgical care improvement project measures and the association with postoperative infections. , 2010, JAMA.

[53]  Y. Tabak,et al.  Surgical site infections: Causative pathogens and associated outcomes. , 2010, American journal of infection control.

[54]  L. Ivashkiv,et al.  Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. , 2010, Arthritis and rheumatism.

[55]  M. Tagawa,et al.  The secreted form of p28 subunit of interleukin (IL)‐27 inhibits biological functions of IL‐27 and suppresses anti‐allogeneic immune responses , 2009, Immunology.

[56]  Y. Okada,et al.  IL-27 Abrogates Receptor Activator of NF-κB Ligand-Mediated Osteoclastogenesis of Human Granulocyte-Macrophage Colony-Forming Unit Cells through STAT1-Dependent Inhibition of c-Fos1 , 2009, The Journal of Immunology.

[57]  Cristina M. Tato,et al.  IL-27 Blocks RORc Expression to Inhibit Lineage Commitment of Th17 Cells , 2009, The Journal of Immunology.

[58]  Shwu-Fen Chang,et al.  The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A. , 2009, American journal of physiology. Cell physiology.

[59]  W. Kelley,et al.  Staphylococcus aureus: new evidence for intracellular persistence. , 2009, Trends in microbiology.

[60]  H. Nakauchi,et al.  Interleukin-27 directly induces differentiation in hematopoietic stem cells. , 2008, Blood.

[61]  I. McInnes,et al.  Interleukin 27 attenuates collagen-induced arthritis , 2008, Annals of the rheumatic diseases.

[62]  T. Yoshimoto,et al.  Effects of IL-23 and IL-27 on osteoblasts and osteoclasts: inhibitory effects on osteoclast differentiation , 2007, Journal of Bone and Mineral Metabolism.

[63]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[64]  L. Webb,et al.  Intracellular Staphylococcus aureus and antibiotic resistance: Implications for treatment of staphylococcal osteomyelitis , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[65]  C. Hunter.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions , 2005, Nature Reviews Immunology.

[66]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[67]  F. D. de Sauvage,et al.  IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and -independent mechanisms , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Thomas L. Smith,et al.  Intracellular Staphylococcus aureus. A mechanism for the indolence of osteomyelitis. , 2003, The Journal of bone and joint surgery. British volume.

[69]  S. Ferretti,et al.  IL-17, Produced by Lymphocytes and Neutrophils, Is Necessary for Lipopolysaccharide-Induced Airway Neutrophilia: IL-15 as a Possible Trigger , 2003, The Journal of Immunology.

[70]  T. Mcclanahan,et al.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.

[71]  K. Bost,et al.  Involvement of Mitogen-Activated Protein Kinase Pathways in Staphylococcus aureus Invasion of Normal Osteoblasts , 2001, Infection and Immunity.

[72]  P. McLardy-Smith,et al.  Prosthetic joint infection , 1999, Current infectious disease reports.

[73]  S. Kaplan.  Recent lessons for the management of bone and joint infections. , 2014, The Journal of infection.

[74]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[75]  F. O'Brien,et al.  Staphylococcus aureus protein A binding to osteoblast tumour necrosis factor receptor 1 results in activation of nuclear factor kappa B and release of interleukin-6 in bone infection. , 2013, Microbiology.

[76]  古川 満.  IL-27 abrogates receptor activator of NF-κB ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos , 2010 .

[77]  J. Anguita,et al.  TRAIL expression is induced in both osteoblasts containing intracellular Staphylococcus aureus and uninfected osteoblasts in infected cultures. , 2008, FEMS microbiology letters.